Heres how some bacteria survive antibioticsMay 1st, 2008 - 1:47 pm ICT by admin
Washington, May 1 (ANI): A team of researchers at the University of Illinois at Chicago have found that some bacteria survive antibiotic treatment by turning on resistance mechanisms when exposed to the drugs.
According to researchers, the findings could lead to more effective antibiotics to treat a variety of infections.
“When patients are treated with antibiotics some pathogenic microbes can turn on the genes that protect them from the action of the drug,” said Alexander Mankin, professor and associate director of the University of Illinois at Chicago’s Center for Pharmaceutical Biotechnology and lead investigator of the study.
“We studied how bacteria can feel the presence of erythromycin and activate production of the resistance genes,” he added.
Erythromycin and newer macrolide antibiotics azithromycin and clarithromycin are often used to treat respiratory tract infections, as well as outbreaks of syphilis, acne and gonorrhea. The drugs can be used by patients allergic to penicillin.
Macrolide antibiotics work by acting upon the ribosomes, the protein-synthesizing factories of the cell.
A newly made protein exits the ribosome through a tunnel that spans the ribosome body.
Antibiotics can keep infection at bay by attaching to the ribosome and preventing proteins the bacterium needs from moving through the tunnel.
Mankin said that some bacteria have learned how to sense the presence of the antibiotic in the ribosomal tunnel, and in response, switch on genes that make them resistant to the drug.
The phenomenon of inducible antibiotic expression was known decades ago, but the molecular mechanism was unknown.
The research team including Nora Vazquez-Laslop, assistant professor in the Center for Pharmaceutical Biotechnology, and undergraduate student Celine Thum used new biochemical and genetic techniques to work out the details of its operation.
“Combining biochemical data with the knowledge of the structure of the ribosome tunnel, we were able to identify some of the key molecular players involved in the induction mechanism,” said Vazquez-Laslop.
“We only researched response to erythromycin-like drugs because the majority of the genetics were already known. There may be other antibiotics and resistance genes in pathogenic bacteria regulated by this same mechanism. This is just the beginning,” she said.
The study is published in the April 24 issue of the journal Molecular Cell. (ANI)
- Antibiotics combo may help fight deadly staph infections - Jan 27, 2010
- Chemical mechanism behind bugs' antibiotic resistance identified - Apr 29, 2011
- Why some combination therapies backfire - Nov 14, 2009
- Antibiotics have long-lasting impacts on gut bacteria: Study - Nov 02, 2010
- Disarming bugs can combat antibiotic resistance - Apr 05, 2012
- Deadly tool in Salmonella's bag of tricks identified - Feb 04, 2011
- Drugs checkmating cancer may combat resistant bugs - Dec 23, 2011
- Scientists crack secret of superbug's resistance - Apr 29, 2011
- Now, antibiotics to combat drug-resistant 'superbugs' - Sep 15, 2010
- Scientists identify new strategy to control antibiotic resistance - Mar 19, 2011
- Common antibiotics, BP medications a bad mix: Study - Jan 18, 2011
- New discovery may help treatment of multi-drug resistant infections - Jan 06, 2011
- Alternatives to antibiotics in sight - Jun 09, 2011
- Snobbish bugs prefer coffee for beverage - Jun 08, 2011
- New compound found effective against resistant microbes - May 28, 2010
Tags: antibiotic treatment, associate director, azithromycin, bacterium, biochemical data, clarithromycin, erythromycin, genetic techniques, macrolide antibiotics, mankin, molecular mechanism, pathogenic microbes, pharmaceutical biotechnology, resistance genes, resistance mechanisms, respiratory tract infections, ribosome, ribosomes, s center, university of illinois at chicago